Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta …

L Martinez, O Cords, Q Liu… - The Lancet Global …, 2022 - thelancet.com
Background BCG vaccines are given to more than 100 million children every year, but there
is considerable debate regarding the effectiveness of BCG vaccination in preventing …

The mycobacterial cell envelope—a moving target

CL Dulberger, EJ Rubin, CC Boutte - Nature Reviews Microbiology, 2020 - nature.com
Mycobacterium tuberculosis, the leading cause of death due to infection, has a dynamic and
immunomodulatory cell envelope. The cell envelope structurally and functionally varies …

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

E Nemes, H Geldenhuys, V Rozot… - … England Journal of …, 2018 - Mass Medical Soc
Abstract Background Recent Mycobacterium tuberculosis infection confers a predisposition
to the development of tuberculosis disease, the leading killer among global infectious …

Digitalization and new technologies for sustainable business models at the ship–port interface: A bibliometric analysis

M Del Giudice, A Di Vaio, R Hassan… - Maritime Policy & …, 2022 - Taylor & Francis
Drawing on the business model innovation theory and the resilience theory, the present
study explores existing literature on the capacity of digitalization and new technologies for …

Immunology of Mycobacterium tuberculosis Infections

JK Sia, J Rengarajan - Microbiology spectrum, 2019 - Am Soc Microbiol
Tuberculosis (TB) is a serious global public health challenge that results in significant
morbidity and mortality worldwide. TB is caused by infection with the bacilli Mycobacterium …

The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era

K Floyd, P Glaziou, A Zumla… - The Lancet Respiratory …, 2018 - thelancet.com
Tuberculosis is the number one cause of death from infectious disease globally and drug-
resistant forms of the disease are a major risk to global health security. On the occasion of …

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

MJA Reid, N Arinaminpathy, A Bloom, BR Bloom… - The Lancet, 2019 - thelancet.com
Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis

L Moreira-Teixeira, PJ Stimpson, E Stavropoulos… - Nature …, 2020 - nature.com
Tuberculosis (TB) is a leading cause of mortality due to infectious disease, but the factors
determining disease progression are unclear. Transcriptional signatures associated with …

What have we learnt about BCG vaccination in the last 20 years?

HM Dockrell, SG Smith - Frontiers in immunology, 2017 - frontiersin.org
A number of new tuberculosis (TB) vaccines have been or are entering clinical trials, which
include genetically modified mycobacteria, mycobacterial antigens delivered by viral …

[HTML][HTML] Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008–2017

Y Pang, J An, W Shu, F Huo, N Chu, M Gao… - Emerging infectious …, 2019 - ncbi.nlm.nih.gov
We investigated the epidemiology of extrapulmonary tuberculosis (TB) among patients
admitted to Beijing Chest Hospital, Beijing, China, during January 2008–December 2017. Of …